Atlas Trials

Study of the Drug B11-FC (Botulism Treatment)

Clinical trial NCT06580236 · UNKNOWN

Trial details

NCT number
NCT06580236
Sponsor
Gamaleya Research Institute of Epidemiology and Microbiology, Health Ministry of the Russian Federation
Status
UNKNOWN
Phase
Phase 1, Phase 2
Study type
INTERVENTIONAL
Botulism
Start date
2024-08-01
Primary completion
2025-03-30
Enrollment
40

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.